510(k) DEN180040

Alethia CMV DNA Amplification Assay, Alethia CMV External Control Kit by Meridian Bioscience, Inc. — Product Code QDZ

DEN180040 is an FDA 510(k) premarket notification submitted by Meridian Bioscience, Inc. for the device "Alethia CMV DNA Amplification Assay, Alethia CMV External Control Kit". The FDA issued a decision of De Novo Granted on November 30, 2018. The device falls under product code QDZ (Qualitative Cytomegalovirus Nucleic Acid-Based Detection Device For Congenital Cytomegalovirus Infection), a Class II device regulated under 21 CFR 866.3181. Meridian Bioscience, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
DENG (De Novo Granted)
Decision Date
November 30, 2018
Date Received
July 30, 2018
Clearance Type
Direct
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Qualitative Cytomegalovirus Nucleic Acid-Based Detection Device For Congenital Cytomegalovirus Infection
Device Class
Class II
Regulation Number
866.3181
Review Panel
MI
Submission Type

The device is a qualitative, in vitro diagnostic test for the direct detection of Cytomegalovirus (CMV) DNA in saliva from newborn babies.